ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Cue Biopharma (CUE)

Technical Analysis Report for NASDAQ stock CUE Cue Biopharma. Dated: 29 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma then click here. or read Experts views on Cue Biopharma or Forecast & share price targets of Cue Biopharma

Cue Biopharma Opened at 0.31 and Closed at: 0.28, which is -17.86% of previous session's close. It moved within a range of 0.26 and 0.36
The session was a Bearish session with an average volume of 3005172, which is -106.5% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.

Support for tomorrow is 0.22 and resistance for tomorrow is 0.32
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 0.24, 0.2 resistance for tomorrow's hourly charts is 0.34, 0.4

10 Day SMA for Cue Biopharma (CUE) is 0.32 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Cue Biopharma (CUE) is 0.43 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Cue Biopharma (CUE) is 0.58 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 0.68 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Cue Biopharma is 0.72 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Cue Biopharma is at 0.43 and 200 DMA is at 0.72, while 50 DMA and 100 DMA are at 0.58 and 0.68 respectively

Cue Biopharma (CUE) moving average of 20 SMA is at 0.43 and 20 EMA is at 0.4

Cue Biopharma (CUE) moving average of 50 SMA is at 0.58 and 50 EMA is at 0.52

Cue Biopharma (CUE) moving average of 100 SMA is at 0.68 and 100 EMA is at 0.65

Cue Biopharma (CUE) moving average of 200 SMA is at 0.72 and 200 EMA is at 0.9

Abeona Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 65.67% more returns!

Anika Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Anika Therapeutics, about 50.87% more returns!

Array Biopharma has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Array Biopharma, about 86.66% more returns!

Atricure Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Atricure Inc, about 68.55% more returns!

Myriad Genetics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Myriad Genetics, about 42.71% more returns!

Outlook Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Outlook Therapeutics, about 59.78% more returns!

Cellectis S has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Cellectis S, about 59.54% more returns!

Phio Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 38.13% more returns!

Collegium Pharmaceutical has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Collegium Pharmaceutical, about 58.92% more returns!

Radnet Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Radnet Inc, about 44.33% more returns!

Ensign Group has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Ensign Group, about 49.35% more returns!

Eton Pharmaceuticals has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Eton Pharmaceuticals, about 62.07% more returns!

Soligenix Inc has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Soligenix Inc, about 46.09% more returns!

Gilead Sciences has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Gilead Sciences, about 53.8% more returns!

Vtv Therapeutics has performed better than Cue Biopharma in short term. You could have earned much better returns by investing in Vtv Therapeutics, about 114.9% more returns!

Cue Biopharma Technical analysis of indicators

Price action analysis of Cue Biopharma (CUE) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Cue Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Cue Biopharma in short term and the sell signal is strong.

Cue Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Cue Biopharma in short term and SELL signal is strong!

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Cue Biopharma is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 0.3 and Cue Biopharma CUE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Cue Biopharma CUE stock. Volume based technical analysis of Cue Biopharma CUE stock is negative.

Cue Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CUE Cue Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CUE Experts View which covers a lot of information including buying and selling signals

CUE future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Cue Biopharma or View Candle Stick Charts here

Chart Cue Biopharma (CUE)  Technical (Analysis) Reports Cue Biopharma [

Videos related to: Cue Biopharma (CUE) Technical (Analysis) Reports Cue Biopharma ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Cue Biopharma (CUE)  Technical (Analysis) Reports Cue Biopharma [

 

Back to top